Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2015-09-24
|
S 81694 (NMS-P153) |
advanced or metastatic solid tumors who have failed previous therapies |
1 |
Servier (France) Nerviano Medical Sciences (Italy) |
Cancer - Oncology |
2015-09-23
|
ADX71149 |
epilepsy |
preclinical |
Addex Therapeutics (Switzerland) Janssen Pharmaceuticals, a J&J company (USA - NJ) |
Neurological diseases - CNS diseases |
2015-09-23
|
apatorsen (OGX-427) |
pancreatic cancer |
2 |
OncoGenex Pharmaceuticals (USA - WA) |
Cancer - Oncology |
2015-09-23
|
ABP 215 (bevacizumab - biosimilar version of Avastin®) |
metastatic non small cell lung cancer |
3 |
Amgen (USA - CA) Allergan (Ireland) |
Cancer - Oncology |
2015-09-22
|
PXS4728A |
NASH (non-alcoholic steatohepatitis) |
1 |
Pharmaxis (Australia) |
Liver diseases - Hepatic diseases |
2015-09-22
|
GLPG1690 |
chronic obstructive pulmonary disease (COPD) |
1 |
Galapagos (Belgium) Janssen Pharmaceutica, a J&J company (USA - NJ) |
Lung diseases - Respiratory diseases |
2015-09-21
|
Envarsus® XR (previously LCP-Tacro™) (tacrolimus) |
prevention of graft rejection in kidney transplantation |
3b |
Veloxis Pharmaceuticals (Denmark) |
Transplantation |
2015-09-21
|
NKTR-214 |
|
preclinical |
Nektar Therapeutics (USA - CA) |
Cancer - Oncology |
2015-09-21
|
ITI-214 |
|
1 |
Intra-Cellular Therapies (USA - NY) |
CNS diseases - Mental diseases |
2015-09-21
|
masitinib |
rheumatoid arthritis |
3 |
AB Science (France) |
Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
2015-09-21
|
BGB324 in combination with immune checkpoint inhibitors |
|
preclinical |
BergenBio (Norway) |
Cancer - Oncology |
2015-09-21
|
sofosbuvir and velpatasvir |
genotype 1-6 chronic hepatitis C virus (HCV) infection |
3 |
Gilead (USA - CA) |
Infectious diseases |
2015-09-20
|
bezlotoxumab |
Clostridium Difficile infection recurrence |
3 |
Merck&Co (USA - NJ) |
Infectious diseases |
2015-09-19
|
delafloxacin |
|
preclinical |
Melinta Therapeutics (USA - CT) |
Infectious diseases |
2015-09-19
|
adeno-associated viral 5 (AAV5) gene therapy - AMT-110 |
Sanfilippo B syndrome (rare autosomal recessive lysosomal storage disease, which manifests in young children) |
1-2 |
Institut Pasteur (France) Inserm (France) AFM-Téléthon (France) Vaincre les Maladies Lysosomales (VML) (France) Uniqure (The Netherlands) |
Rare diseases |
2015-09-19
|
CureXcell® |
chronic venous leg ulcers |
3 |
Macrocure (Israel) |
Cardiovascular diseases |
2015-09-18
|
Ad-RTS-IL-12 |
advanced melanoma, breast cancer, glioblastoma, colon cancer |
preclinical, 2 |
Ziopharm Oncology (USA - MA) |
Cancer - Oncology |
2015-09-18
|
bacteriophage cocktail against Staphylococcus aureus |
|
preclinical |
AmpliPhi BioSciences (USA - VA) |
Infectious diseases |
2015-09-18
|
pembrolizumab (MK-3475) |
metastatic triple negative breast cancer |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2015-09-17
|
VGX-3100 |
cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18 |
2b |
Inovio Pharmaceuticals (USA - PA) |
Infectious diseases - Women health - Cancer - Oncology |